论文部分内容阅读
1病例介绍患者女,55岁。因“右肺阴影1+年,右肺腺癌靶向治疗后9个月”于2014年11月11日入我院拟行手术治疗。患者1年前体检发现右肺阴影,考虑结核,抗结核治疗5个月后复查右肺阴影增大。10个月前无明显诱因出现右胸痛,伴咳白色痰,来我院住院检查,发现右侧胸腔积液,行胸水脱落细胞检查,诊断为腺癌。于2014年2月开始院外行靶向治疗9个月:口服吉非替尼250 mg,1次/d。于2014年11月8日门诊复查胸部CT示:右肺、右侧叶间裂及右
1 case description Female patient, 55 years old. Due to “right lung shadow 1+ years, right lung adenocarcinoma targeted therapy 9 months ” on November 11, 2014 into our hospital for surgical treatment. Patient 1 year ago physical examination found the right lung shadow, consider tuberculosis, anti-TB treatment 5 months after the review of the right lung shadow increased. 10 months ago no obvious incentive to appear right chest pain, cough and white sputum, to our hospital, and found that the right pleural effusion, pleural effusion cytology, diagnosis of adenocarcinoma. In February 2014, he started out-of-hospital targeted therapy for 9 months: gefitinib 250 mg once daily. On November 8, 2014, an outpatient review of the chest CT showed the right lung, the right interlobular cleft, and the right